Disability Health Japan Kobayashi Pharmaceutical Co.

Shareholders of ‘Beni-koji’ Scandal-Hit Pharmaceutical Company Approve Board Nominees

Shareholders of Kobayashi Pharmaceutical Co. on Friday approved the company's proposed slate of 10 board nominees, including executive officer Norikazu Toyoda, who is set to become new president and CEO of the scandal-tainted Japanese company.

Unknown's avatar
by Michael Gillan Peckitt
Comments 0

From Jiji

March 28 2025

OSAKA – Shareholders of Kobayashi Pharmaceutical Co. on Friday approved the company’s proposed slate of 10 board nominees, including executive officer Norikazu Toyoda, who is set to become new president and CEO of the scandal-tainted Japanese company.

The 10 also include Yoshihito Ota, who helped turn around Japan Airlines and will become chairman of the drugmaker.

0 comments on “Shareholders of ‘Beni-koji’ Scandal-Hit Pharmaceutical Company Approve Board Nominees”

Leave a comment